Advertisement
Research Report| Volume 64, ISSUE 3, P241-247, August 01, 2008

Limbic and Frontal Cortical Degeneration Is Associated with Psychiatric Symptoms in PINK1 Mutation Carriers

Published:February 13, 2008DOI:https://doi.org/10.1016/j.biopsych.2007.12.010

      Background

      Mutations in the PINK1 gene can cause Parkinson's disease and are frequently associated with psychiatric symptoms that might even precede motor signs.

      Methods

      To determine whether specific gray matter degeneration of limbic and frontal structures might be liable to different psychiatric symptoms in PINK1 mutation carriers, observer-independent voxel-based morphometry was applied to high-resolution magnetic resonance images of 14 PINK1 mutation carriers from a large German family and 14 age- and gender-matched healthy control subjects.

      Results

      Psychiatric diagnoses in PINK1 mutation carriers comprised major depression without psychotic symptoms and schizophrenia-spectrum, panic, adjustment, and obsessive-compulsive personality disorders. As hypothesized, the categorical comparison between all PINK1 mutation carriers and control subjects demonstrated atrophy of limbic structures, especially the hippocampus and parahippocampus. More specifically, multiple regression analysis considering all psychiatric subscores simultaneously displayed different frontal (prefrontal, dorsolateral, and premotor cortex) and limbic (parahippocampus and cingulate) degeneration patterns. The duration of the psychiatric disease was also correlated with the extent of limbic and frontal gray matter volume decrease.

      Conclusions

      Our results support the hypothesis that limbic and frontal gray matter alterations could explain various psychiatric symptoms observed in PINK1 mutation carriers. Factors determining individual susceptibility to degeneration of certain brain areas remain to be elucidated in future studies.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schrag A.
        Psychiatric aspects of Parkinson's disease—an update.
        J Neurol. 2004; 251: 795-804
        • Ramirez A.
        • Heimbach A.
        • Grundeman J.
        • Stiller B.
        • Hampshire D.
        • Cid L.P.
        • et al.
        Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.
        Nat Genet. 2006; 38: 1184-1190
        • Klein C.
        • Schlossmacher M.G.
        The genetics of Parkinson disease: Implications for neurological care.
        Nat Clin Pract Neurol. 2006; 2: 136-146
        • Bonifati V.
        • Rohe C.F.
        • Breedveld G.J.
        • Fabrizio E.
        • De Mari M.
        • Tassorelli C.
        • et al.
        Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes.
        Neurology. 2005; 65: 87-95
        • Hedrich K.
        • Hagenah J.
        • Djarmati A.
        • Hiller A.
        • Lohnau T.
        • Lasek K.
        • et al.
        Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: Role of a single hit?.
        Arch Neurol. 2006; 63: 833-838
        • Shiba M.
        • Bower J.H.
        • Maraganore D.M.
        • McDonnell S.K.
        • Peterson B.J.
        • Ahlskog J.E.
        • et al.
        Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study.
        Mov Disord. 2000; 15: 669-677
        • Gonera E.G.
        • van't Hof M.
        • Berger H.J.
        • van Weel C.
        • Horstink M.W.
        Symptoms and duration of the prodromal phase in Parkinson's disease.
        Mov Disord. 1997; 12: 871-876
        • Hubble J.P.
        • Cao T.
        • Hassanein R.E.
        • Neuberger J.S.
        • Koller W.C.
        Risk factors for Parkinson's disease.
        Neurology. 1993; 43: 1693-1697
        • Dooneief G.
        • Mirabello E.
        • Bell K.
        • Marder K.
        • Stern Y.
        • Mayeux R.
        An estimate of the incidence of depression in idiopathic Parkinson's disease.
        Arch Neurol. 1992; 49: 305-307
        • Oertel W.H.
        • Hoglinger G.U.
        • Caraceni T.
        • Girotti F.
        • Eichhorn T.
        • Spottke A.E.
        • et al.
        Depression in Parkinson's disease.
        Adv Neurol. 2001; 86: 373-383
        • Aarsland D.
        • Larsen J.P.
        • Lim N.G.
        • Janvin C.
        • Karlsen K.
        • Tandberg E.
        • et al.
        Range of neuropsychiatric disturbances in patients with Parkinson's disease.
        J Neurol Neurosurg Psychiatry. 1999; 67: 492-496
        • Hatano Y.
        • Li Y.
        • Sato K.
        • Asakawa S.
        • Yamamura Y.
        • Tomiyama H.
        • et al.
        Novel PINK1 mutations in early-onset parkinsonism.
        Ann Neurol. 2004; 56: 424-427
        • Khan N.L.
        • Graham E.
        • Critchley P.
        • Schrag A.E.
        • Wood N.W.
        • Lees A.J.
        • et al.
        Parkin disease: A phenotypic study of a large case series.
        Brain. 2003; 126: 1279-1292
        • Rohe C.F.
        • Montagna P.
        • Breedveld G.
        • Cortelli P.
        • Oostra B.A.
        • Bonifati V.
        Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism.
        Ann Neurol. 2004; 56: 427-431
        • Steinlechner S.
        • Stahlberg J.
        • Völkel B.
        • Djarmati A.
        • Hagenah J.
        • Hiller A.
        • et al.
        Co-occurence of affective and schizophrenia spectrum disorders with PINK1 mutations.
        JNNP. 2007; 78: 532-535
        • Klein C.
        • Pramstaller P.P.
        • Kis B.
        • Page C.C.
        • Kann M.
        • Leung J.
        • et al.
        Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype.
        Ann Neurol. 2000; 48: 65-71
        • Hedrich K.
        • Kann M.
        • Lanthaler A.J.
        • Dalski A.
        • Eskelson C.
        • Landt O.
        • et al.
        The importance of gene dosage studies: Mutational analysis of the parkin gene in early-onset parkinsonism.
        Hum Mol Genet. 2001; 10: 1649-1656
        • Kann M.
        • Jacobs H.
        • Mohrmann K.
        • Schumacher K.
        • Hedrich K.
        • Garrels J.
        • et al.
        Role of parkin mutations in 111 community-based patients with early-onset parkinsonism.
        Ann Neurol. 2002; 51: 621-625
        • Binkofski F.
        • Reetz K.
        • Gaser C.
        • Hilker R.
        • Hagenah J.
        • Hedrich K.
        • et al.
        Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
        Neurology. 2007; 69: 842-850
        • Good C.D.
        • Johnsrude I.S.
        • Ashburner J.
        • Henson R.N.
        • Friston K.J.
        • Frackowiak R.S.
        A voxel-based morphometric study of ageing in 465 normal adult human brains.
        Neuroimage. 2001; 14: 21-36
        • Job D.E.
        • Whalley H.C.
        • McConnell S.
        • Glabus M.
        • Johnstone E.C.
        • Lawrie S.M.
        Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia.
        Schizophr Res. 2003; 64: 1-13
        • Chua S.E.
        • Cheung C.
        • Cheung V.
        • Tsang J.T.
        • Chen E.Y.
        • Wong J.C.
        • et al.
        Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia.
        Schizophr Res. 2007; 89: 12-21
        • Wright I.C.
        • Rabe-Hesketh S.
        • Woodruff P.W.
        • David A.S.
        • Murray R.M.
        • Bullmore E.T.
        Meta-analysis of regional brain volumes in schizophrenia.
        Am J Psychiatry. 2000; 157: 16-25
        • Frodl T.
        • Schaub A.
        • Banac S.
        • Charypar M.
        • Jager M.
        • Kummler P.
        • et al.
        Reduced hippocampal volume correlates with executive dysfunctioning in major depression.
        J Psychiatry Neurosci. 2006; 31: 316-325
        • Wu J.
        • Buchsbaum M.S.
        • Gillin J.C.
        • Tang C.
        • Cadwell S.
        • Wiegand M.
        • et al.
        Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex.
        Am J Psychiatry. 1999; 156: 1149-1158
        • Benedetti F.
        • Bernasconi A.
        • Pontiggia A.
        Depression and neurological disorders.
        Curr Opin Psychiatry. 2006; 19: 14-18
        • Sheline Y.I.
        • Gado M.H.
        • Kraemer H.C.
        Untreated depression and hippocampal volume loss.
        Am J Psychiatry. 2003; 160: 1516-1518
        • Benjamini Y.
        • Hochberg Y.
        Controlling the false discovery rate: A practical and powerful approach to multiple testing.
        J Roy Stat Soc. 2000; 57: 289-300
        • Maldjian J.A.
        • Laurienti P.J.
        • Kraft R.A.
        • Burdette J.H.
        An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.
        Neuroimage. 2003; 19: 1233-1239
        • Goldstein J.M.
        • Goodman J.M.
        • Seidman L.J.
        • Kennedy D.N.
        • Makris N.
        • Lee H.
        • et al.
        Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging.
        Arch Gen Psychiatry. 1999; 56: 537-547
        • Gur R.E.
        • Turetsky B.I.
        • Bilker W.B.
        • Gur R.C.
        Reduced gray matter volume in schizophrenia.
        Arch Gen Psychiatry. 1999; 56: 905-911
        • Heckers S.
        • Konradi C.
        Hippocampal neurons in schizophrenia.
        J Neural Transm. 2002; 109: 891-905
        • McDonald C.
        • Bullmore E.T.
        • Sham P.C.
        • Chitnis X.
        • Wickham H.
        • Bramon E.
        • et al.
        Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes.
        Arch Gen Psychiatry. 2004; 61: 974-984
        • Smith M.E.
        Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: A meta-analysis of structural MRI studies.
        Hippocampus. 2005; 15: 798-807
        • Kantarci K.
        • Jack Jr., C.R.
        Neuroimaging in Alzheimer disease: An evidence-based review.
        Neuroimaging Clin N Am. 2003; 13: 197-209
        • Bremner J.D.
        • Narayan M.
        • Anderson E.R.
        • Staib L.H.
        • Miller H.L.
        • Charney D.S.
        Hippocampal volume reduction in major depression.
        Am J Psychiatry. 2000; 157: 115-118
        • Dhikav V.
        • Anand K.S.
        Is hippocampal atrophy a future drug target?.
        Med Hypotheses. 2007; 68: 1300-1306
        • Maclean P.D.
        The limbic system (“visceral brain”) and emotional behavior.
        AMA Arch Neurol Psychiatry. 1955; 73: 130-134
        • Hadland K.A.
        • Rushworth M.F.
        • Gaffan D.
        • Passingham R.E.
        The effect of cingulate lesions on social behaviour and emotion.
        Neuropsychologia. 2003; 41: 919-931
        • Voigt B.A.
        • Laureys S.
        Posterior cingulate, precuneal and retrosplenial cortices: cytology and components of the neural network correlates of consciousness.
        Prog Brain Res. 2005; 150: 205-217
        • Kennerley S.W.
        • Walton M.E.
        • Behrens T.E.
        • Buckley M.J.
        • Rushworth M.F.
        Optimal decision making and the anterior cingulate cortex.
        Nat Neurosci. 2006; 9: 940-947
        • Volz K.G.
        • Schubotz R.I.
        • von Cramon D.Y.
        Decision-making and the frontal lobes.
        Curr Opin Neurol. 2006; 19: 401-406
        • Volz K.G.
        • Schubotz R.I.
        • von Cramon D.Y.
        Variants of uncertainty in decision-making and their neural correlates.
        Brain Res Bull. 2005; 67: 403-412
        • Shenton M.E.
        • Dickey C.C.
        • Frumin M.
        • McCarley R.W.
        A review of MRI findings in schizophrenia.
        Schizophr Res. 2001; 49: 1-52
        • Lawrie S.M.
        • Abukmeil S.S.
        Brain abnormality in schizophrenia.
        Br J Psychiatry. 1998; 172: 110-120
        • Quirk G.J.
        • Garcia R.
        • Gonzalez-Lima F.
        Prefrontal mechanisms in extinction of conditioned fear.
        Biol Psychiatry. 2006; 60: 337-343
        • Sotres-Bayon F.
        • Bush D.E.
        • LeDoux J.E.
        Emotional perseveration: An update on prefrontal-amygdala interactions in fear extinction.
        Learn Mem. 2004; 11: 525-535
        • Shackman A.J.
        • Sarinopoulos I.
        • Maxwell J.S.
        • Pizzagalli D.A.
        • Lavric A.
        • Davidson R.J.
        Anxiety selectively disrupts visuospatial working memory.
        Emotion. 2006; 6: 40-61
        • Taymans J.M.
        • Van den Haute C.
        • Baekelandt V.
        Distribution of PINK1 and LRRK2 in rat and mouse brain.
        J Neurochem. 2006; 98: 951-961